ORIC Pharmaceuticals (ORIC) Insider Trading & Ownership $8.95 +0.08 (+0.90%) (As of 12/6/2023 ET) Add Compare Share Share Today's Range$8.63▼$9.1750-Day Range$5.41▼$8.9552-Week Range$2.91▼$9.79Volume517,277 shsAverage Volume342,192 shsMarket Capitalization$488.23 millionP/E RatioN/ADividend YieldN/APrice Target$16.29 Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainability ORIC Pharmaceuticals (NASDAQ:ORIC) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage5.34%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)2Amount OfInsider Selling(Last 12 Months)$305,022.69 Get ORIC Insider Trade Alerts Want to know when executives and insiders are buying or selling ORIC Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ORIC Insider Buying and Selling by Quarter ORIC Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails7/10/2023Jacob ChackoCEOSell10,508$8.01$84,169.08 7/5/2023Jacob ChackoCEOSell4,336$8.01$34,731.36 6/26/2023Jacob ChackoCEOSell20,000$8.03$160,600.00 12/15/2022Jacob ChackoCEOSell5,764$3.25$18,733.00 12/15/2022Pratik S MultaniInsiderSell2,089$3.25$6,789.25 (Data available from 1/1/2013 forward) ORIC Insider Trading Activity - Frequently Asked Questions Who is on ORIC Pharmaceuticals's Insider Roster? The list of insiders at ORIC Pharmaceuticals includes Carl L Gordon, Dominic Piscitelli, Jacob Chacko, Orbimed Advisors Llc, Pratik S Multani, Richard A Heyman, and Richard H Scheller. Learn more on insiders at ORIC. What percentage of ORIC Pharmaceuticals stock is owned by insiders? 5.34% of ORIC Pharmaceuticals stock is owned by insiders. Learn more on ORIC's insider holdings. Which ORIC Pharmaceuticals insiders have been buying company stock? The following insiders have purchased ORIC shares in the last 24 months: Dominic Piscitelli ($321,600.00), and Jacob Chacko ($2,605,280.10). How much insider buying is happening at ORIC Pharmaceuticals? Insiders have purchased a total of 747,773 ORIC shares in the last 24 months for a total of $2,926,880.10 bought. Which ORIC Pharmaceuticals insiders have been selling company stock? The following insiders have sold ORIC shares in the last 24 months: Jacob Chacko ($298,233.44), and Pratik S Multani ($6,789.25). How much insider selling is happening at ORIC Pharmaceuticals? Insiders have sold a total of 42,697 ORIC Pharmaceuticals shares in the last 24 months for a total of $305,022.69 sold. More Insider Trading Tools from MarketBeat Related Companies: Phibro Animal Health Insider Buying Phathom Pharmaceuticals Insider Buying Lyell Immunopharma Insider Buying Seelos Therapeutics Insider Buying Bicycle Therapeutics Insider Buying 23andMe Insider Buying Edgewise Therapeutics Insider Buying Entrada Therapeutics Insider Buying SIGA Technologies Insider Buying COMPASS Pathways Insider Buying Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: The most active insider sales: Stocks to put on your radarChoose these agricultural stocks to finish the year strongFeel like buying the dip on Best Buy? Your gut may be rightThe top 3 stocks insiders are selling, but you shouldn’tSimon Property Group's 7.2% Dividend Has Insiders Buying In Bulk This page (NASDAQ:ORIC) was last updated on 12/7/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ORIC Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.